期刊文献+

先天性心脏病肺动脉高压机制的研究进展 被引量:4

Research Progress in Mechanism of Congenital Heart Disease with Pulmonary Hypertension
下载PDF
导出
摘要 先天性心脏病(简称先心病)合并肺动脉高压是严重影响我国儿童身心健康的主要疾病之一,其复杂的发病机制仍未完全明了。但是,近年来对于先心病病理生理条件的动物模型的建立、肺组织的病理学资料与血液分子水平的生化指标的研究日益增多,并已取得较大进展。本文综述了近几年来国内外有关先心病、PH发病机制的研究进展,以便能更深入理解其机制,指导临床治疗。 Congenital heart disease (CHD)with pulmonary hypertension is one of the most serious diseases that influence the children's health in both body and mind in our country,whose complex pathogenic mechanism is not completely clear now. The increasing study of the establishment of animal model with congenital heart disease , pathologic data of lung tissue and blood biochemical indicator in molecular level has achieved a great progress. This article reviews research progress of internal and abroad congenital heart disease and pathogenesis of PH in order to understant its mechanism further and then instruct clinical therapy.
出处 《医学综述》 2007年第6期453-455,共3页 Medical Recapitulate
关键词 先天性心脏病 肺动脉高压 发病机制 Congenital heart disease Pulmonary hypertension Pathogenic mechanism
  • 相关文献

参考文献20

二级参考文献19

  • 1Rabinovitsh M. Pathophysiology of pulmonary hyperten sion. In: Emmanouilides GC, Riemenscheider TA, Allen HD. eds. Moss and Adams: Heart disease in infants, children, and adolescents, including the fetus and youngadult. 5th ed. Maryland: Williams&Wilkines Co. 1995: 1659- 1695.
  • 2Forstermann U, Kleinert H, Gath I, et al. Expression and expressional control of nitric oxide synthase in various cell types. In: Ignarro L. ed. Nitric oxide: Biochemistry, molecular biology, and therapeutic implications. 1st ed. Academic Press, Inc. California, 1995: 171 - 186.
  • 3Barnes PJ, Liu SF. Regulation of pulmonary vascular tone. Pharmacol Rev, 1995, 47: 88- 120.
  • 4Frostell CG, Fratacci MD, Wain JC, et al. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 1991,83: 2038 - 2047.
  • 5Hoffmann GM, Ross GA, Day SE , et al . Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med, 1997, 25: 352 - 359.
  • 6Kouyoumdjian C, Adnot S, Levane M, et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest, 1994, 94: 578-584.
  • 7Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest, 1998, 114: 208s- 212s.
  • 8Mason NA, Springall DR, Burke M, et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol, 1998, 185: 313-318.
  • 9Hislop AA, Springall DR, Oliverira H, et al. Endothelial nitric oxide synthase in hypoxic newborn porcine pul monary vessels. Arch Dis Child, 1997, 77: F16- F22.
  • 10Ziche M,Morbidelli L,Choudhuri R,et al.Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis[].The Journal of Clinical Investigation.1997

共引文献31

同被引文献26

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部